Anaplastic meningioma versus meningeal hemangiopericytoma: Immunohistochemical and genetic markers

Human Pathology

Volumn 35, Issue 11, 2004, Pages 1413-1418

  Rajaram, Veena ^a   Brat, Daniel J ^a   Perry, Arie ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anaplastic meningiomas; EMA; epithelial membrane antigen; Factor XIIIa; FISH; fluorescence in situ hybridization; FXIIIa; hemangiopericytoma; HPC; immunohistochemistry; meningeal hemangiopericytomas; meningioma; MIII; tumor genetics

Indexed keywords

BLOOD CLOTTING FACTOR 13; CD99 ANTIGEN; CLAUDIN 1; PROTEIN BCL 2;

ARTICLE; CHROMOSOME 1; CHROMOSOME 14Q; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENETIC MARKER; HEMANGIOPERICYTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENINGIOMA; MOLECULAR PROBE; NEUROPATHOLOGY;

DNA, NEOPLASM; GENETIC MARKERS; HEMANGIOPERICYTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MENINGEAL NEOPLASMS; MENINGIOMA; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 10044275061     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.07.017     Document Type: Article

References (28)

1. Renshaw A.A., Paulus W., Joseph J.T. CD34 and epithelial membrane antigen distinguish dural hemangiopericytoma and meningioma. Appl Neurochem. 3:1995;108-114
2. Nemes Z. Differentiation markers in hemangiopericytoma. Cancer. 69:1992;133-140
3. Moss T.H. Immunohistochemical characteristics of haemangiopericytic meningiomas Comparison with typical meningiomas, haemangioblastomas and haemangiopericytomas from extracranial sites. Neuropathol Appl Neurobiol. 13:1987;467-480
4. Iwaki T., Fukui M., Takeshita I., et al. Hemangiopericytoma of the meninges A clinicopathologic and immunohistochemical study. Clin Neuropathol. 7:1988;93-99
5. Perry A., Scheithauer B.W., Nascimento A.G. The immunophenotypic spectrum of meningeal hemangiopericytoma A comparison with fibrous meningioma and solitary fibrous tumor of meninges. Am J Surg Pathol. 21:1997;1354-1360
6. Alawi F., Stratton D., Freedman P.D. Solitary fibrous tumor of the oral soft tissues A clinicopathologic and immunohistochemical study of 16 cases. Am J Surg Pathol. 25:2001;900-910
7. D'Amore E.S., Manivel J.C., Sung J.H. Soft-tissue and meningeal hemangiopericytomas An immunohistochemical and ultrastructural study. Hum Pathol. 21:1990;414-423
8. Cummings T.J., Burchette J.L., McLendon R.E. CD34 and dural fibroblasts The relationship to solitary fibrous tumor and meningioma. Acta Neuropathol (Berl). 102:2001;349-354
9. Guillou L., Gebhard S., Coindre J.M. Lipomatous hemangiopericytoma: A fat-containing variant of solitary fibrous tumor? Clinicopathologic, immunohistochemical, and ultrastructural analysis of a series in favor of a unifying concept. Hum Pathol. 31:2000;1108-1115
10. Tihan T., Viglione M., Rosenblum M.K., et al. Solitary fibrous tumors in the central nervous system. A clinicopathologic review of 18 cases and comparison to meningeal hemangiopericytomas. Arch Pathol Lab Med. 127:2003;432-439
11. Bhattacharjee M., Adesina A.M., Goodman C., et al. Claudin-1 expression in meningiomas and schwannomas Possible role in differential diagnosis. J Neuropathol Exp Neurol. 62:2003;581
12. Folpe A.L., Billings S.D., McKenney J.K., et al. Expression of claudin-1, a recently described tight junction-associated protein, distinguishes soft tissue perineurioma from potential mimics. Am J Surg Pathol. 26:2002;1620-1626
13. Wolburg H., Wolburg-Buchholz K., Liebner S., et al. Claudin-1, claudin-2 and claudin-11 are present in tight junctions of choroid plexus epithelium of the mouse. Neurosci Lett. 307:2001;77-80
14. Cai D.X., Banerjee R., Scheithauer B.W., et al. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma Diagnostic and prognostic implications. J Neuropathol Exp Neurol. 60:2001;628-636
15. Gutmann D.H., Donahoe J., Perry A., et al. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum Mol Genet. 9:2000;1495-1500
16. Perry A., Cai D.X., Scheithauer B.W., et al. Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma a correlative immunohistochemical study of 175 cases. J Neuropathol Exp Neurol. 59:2000;872-879
17. Watson M.A., Gutmann D.H., Peterson K., et al. Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am J Pathol. 161:2002;665-672
18. Weber R.G., Bostrom J., Wolter M., et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas Toward a genetic model of meningioma progression. Proc Natl Acad Sci U S A. 94:1997;14719-14724
19. Gutmann D.H., Hirbe A.C., Huang Z.Y., et al. The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion. Neurobiol Dis. 8:2001;266-278
20. Louis D.N., Scheithauer B.W., Budka H., et al. Meningiomas. Kleihues P. C.W. World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. 2000;176-184 IARC Press, Lyon, France
21. Winek R.R., Scheithauer B.W., Wick M.R. Meningioma, meningeal hemangiopericytoma (angioblastic meningioma), peripheral hemangiopericytoma, and acoustic schwannoma. A comparative immunohistochemical study. Am J Surg Pathol. 13:1989;251-261
22. Pena C.E. Meningioma and intracranial hemangiopericytoma. A comparative electron microscopic study. Acta Neuropathol (Berl). 39:1977;69-74
23. Jaaskelainen J., Louis D.N., Paulus W., et al. Hemangiopericytoma. Kleihues P. C.W. World Health Organization classification of tumors. Pathology and Genetics of tumors of the Nervous System. 2000;190-192 IARC Press, Lyon
24. Ono Y., Ueki K., Joseph J.T., et al. Homozygous deletions of the CDKN2/p16 gene in dural hemangiopericytomas. Acta Neuropathol (Berl). 91:1996;221-225
25. Perry A., Banerjee R., Lohse C.M., et al. A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas. Brain Pathol. 12:2002;183-190
26. Tse J.Y., Ng H.K., Lo K.W., et al. Analysis of cell cycle regulators p16INK4A, pRb, and CDK4 in low- and high-grade meningiomas. Hum Pathol. 29:1998;1200-1207
27. Henn W., Wullich B., Thonnes M., et al. Recurrent t(12;19)(q13;q13.3) in intracranial and extracranial hemangiopericytoma. Cancer Genet Cytogenet. 71:1993;151-154
28. Herath S.E., Stalboerger P.G., Dahl R.J., et al. Cytogenetic studies of four hemangiopericytomas. Cancer Genet Cytogenet. 72:1994;137-140